The pharma industry just got some big news this week. International pharmaceutical company Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd, just announced a licensing arrangement for SPARC’s Elepsia XR. Elepsia XR is a novel investigational product designed as an extended release formulation of levetiracetam 1000 mg and 1500 mg. Levetiracetam is … Continue reading “Epilepsy Drug Agreement Sends SPARC Shares Flying”
Biotech & Pharma
Bayer To Offer $125 Per Share For Monsanto (MON)
German company Bayer has just upped the ante on its offer for US biotech seeds…
Cyrotherapy Could Be Fatal According to FDA
One of the most popular treatments among athletes and celebrities is cyrotherapy. It involves exposure…
Period Proof Underwear Could Be The New Craze
The feminine hygiene market is worth $15 billion, a whopping number that makes sense as…
Tesaro (TSRO) Shares Double On Cancer Drug Success
You know champagne bottles are being popped open when your cancer drug treatment trial ends…
AstraZeneca (AZN) Battles Crestor Competition
AstraZeneca recently received FDA approval to use Crestor, its blockbuster cholestrol drug, to treat children…
This New Vaccine Could Treat Multiple Sclerosis
Multiple Sclerosis is one of the most severe diseases in the neurodegenartive autoimmune family. Protective…
Ackman’s New Video Has Herbalife (HLF) Shares Popping
Billionaire investor William Ackman has made it no secret that he is against Herbalife, the…
Cat Allergy Sent This Pharma Company Plummeting
British biotech company Circassia Pharmaceuticals sank on Monday after its experimental cat allergy treatment failed…
This Common Cancer Treatment May Disappear
It makes absolutely no sense for an effective cancer treatment to vanish from the market,…
Your Hot Tea Could Cause Cancer
Just when we thought the list couldn't get any longer. One more thing has just…
This New Drug Could Help Psoriasis Sufferers
Between 2 to 4 percent of the population suffers from Psoriasis and those who have…
Cantabio Pharmaceuticals Inc. (CTBO) Targets Alzheimer’s
More than 700,000 seniors are expected to die this year from Alzheimer's disease. It is…
Overdosing On Anti-diarrhea Drugs.. Yeah, It’s A Thing
Most of us realize we are in an epidemic when it comes to overdosing on…
